+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Digital Pathology Market by Type, Product, Laboratory Throughput, Deployment Model, Application, End User - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 4791773
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Digital Pathology Market is projected to reach USD 1.66 Billion in 2026. It is expected to continue growing at a CAGR of 16.05%, reaching USD 4.09 Billion by 2032.

Digital pathology is reshaping anatomic pathology by converting glass-slide workflows into connected, image-based diagnostic ecosystems. The market centers on whole slide imaging, image management systems, laboratory information system integration, computational pathology, telepathology, and regulated artificial intelligence tools that support pathologists in high-volume clinical and research settings.

Adoption is being driven by sustained growth in oncology testing, expanding precision medicine programs, pathology workforce shortages, and the need for faster subspecialty consultation across distributed health systems. Regulatory milestones have also increased confidence: the U.S. Food and Drug Administration authorized the first whole slide imaging system for primary diagnosis in 2017, and the College of American Pathologists has published validation guidance for clinical whole slide imaging implementation.

For industry vendors, digital pathology is no longer a limited research or education tool. It is becoming an enterprise infrastructure layer for diagnostic quality, workload balancing, biomarker quantification, data-rich pathology archives, and AI-enabled clinical decision support.

Transformative Shifts in the Digital Pathology Landscape

The digital pathology landscape is shifting from scanner-led purchasing to enterprise workflow transformation. Hospitals, reference laboratories, academic medical centers, and pharmaceutical research organizations are evaluating platforms based on interoperability, diagnostic-grade image quality, uptime, cybersecurity, data governance, and integration with LIS, PACS, cloud, and laboratory automation systems.

A second major shift is the move from local deployment to hybrid and cloud-enabled architectures. High-resolution whole slide images generate large data volumes, making storage strategy, compression, retrieval speed, and vendor-neutral image access central to procurement decisions. DICOM-compatible pathology imaging and HL7-based connectivity are becoming increasingly important as pathology converges with radiology, genomics, and oncology informatics.

The competitive landscape is also evolving from hardware differentiation toward end-to-end value. Scanner throughput, z-stack capability, image fidelity, AI readiness, validation support, and global service coverage now influence purchasing decisions as much as device specifications.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is compounding the value of digital pathology by turning whole slide images into structured, searchable, and quantifiable diagnostic assets. Current AI use cases include tumor detection, tissue segmentation, mitotic counting, quality control, workload triage, and biomarker scoring support. In 2021, the U.S. Food and Drug Administration authorized an AI-based tool to help pathologists identify areas suspicious for cancer in prostate biopsy images, signaling the transition from research algorithms to regulated clinical support.

The cumulative impact of AI is strongest when algorithms are embedded into validated workflows rather than deployed as standalone tools. Pathologists remain accountable for diagnosis, while AI can reduce repetitive visual search, improve consistency in quantification, and help prioritize complex or time-sensitive cases.

Responsible adoption requires site-specific validation, human-in-the-loop oversight, dataset diversity, audit trails, cybersecurity controls, and continuous performance monitoring. As foundation models and multimodal pathology systems mature, the highest-value applications will combine image data with clinical, molecular, and treatment-response data.

Key Regional Insights

North America remains one of the most advanced regions for digital pathology adoption, supported by large integrated health systems, academic cancer centers, reference laboratories, established regulatory pathways, and strong investment in computational pathology. The United States leads in regulated clinical adoption, while Canada benefits from provincial telepathology initiatives and geographically distributed care models that support remote consultation across wide service areas.

Europe is progressing through national health digitization programs, cancer network modernization, and regulated in vitro diagnostic frameworks. The United Kingdom has established notable digital pathology deployments within public health-linked networks, while Germany, France, Italy, and Spain are increasing investment in hospital digitization and oncology diagnostics. European Union IVDR requirements are raising expectations for clinical evidence, traceability, and post-market surveillance.

Asia-Pacific is expanding rapidly because of high diagnostic volumes, rising cancer incidence, and strong digital health initiatives in China, Japan, South Korea, India, and Australia. Latin America is led by Brazil and Mexico, where private laboratory networks and urban specialty centers are early adopters. The Middle East, particularly GCC healthcare systems, is investing in smart hospitals and advanced oncology infrastructure, while Africa shows growing telepathology relevance in response to pathologist shortages, geographic access gaps, and the need for remote specialist review.

Key Group Insights

The European Union is shaping digital pathology through harmonized regulatory expectations, cross-border health data initiatives, and hospital digitization funding. EU-wide emphasis on interoperability, IVDR compliance, cybersecurity, and evidence-based procurement is pushing suppliers and healthcare systems to provide transparent validation data, lifecycle support, and traceable clinical performance documentation.

G7 markets are setting the pace for regulated adoption because they combine mature healthcare reimbursement structures, advanced oncology programs, high pathology informatics maturity, and strong academic research capacity. NATO countries show overlapping demand for secure health data infrastructure, resilient medical supply chains, and interoperable digital systems that can support civilian and military medical readiness.

BRICS economies represent a scale-driven opportunity, with China and India offering high-volume diagnostic demand, Brazil strengthening regional laboratory networks, Russia maintaining interest in domestic health technology capacity, and South Africa reinforcing the role of telepathology in specialist access. ASEAN adoption is uneven but promising, with Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines pursuing digital health modernization at different speeds. The GCC is one of the most active groups for premium healthcare infrastructure, led by Saudi Arabia, the United Arab Emirates, Qatar, and other states investing in oncology centers, smart hospitals, and AI-enabled care delivery.

Key Country Insights

The United States is the most influential digital pathology market because of FDA-authorized systems, large reference laboratories, academic medical centers, and strong investment in pathology AI. Canada is advancing through provincial care models and remote pathology consultation needs, while Mexico is growing through private diagnostics networks and medical tourism-linked specialty care. Brazil is the leading Latin American opportunity, supported by major urban laboratory groups and expanding oncology services.

In Europe, the United Kingdom is notable for public health-linked digital pathology networks and cancer pathway modernization. Germany combines high healthcare expenditure with strong medical technology infrastructure, while France is advancing hospital digitization and oncology diagnostics. Italy and Spain are adopting digital workflows through regional hospital systems and research hospitals, and Russia remains focused on domestic diagnostic capacity and large-scale public healthcare needs.

In Asia-Pacific, China offers scale, domestic scanner development, and hospital digitization momentum, while India has strong demand due to diagnostic volume and pathologist access gaps. Japan emphasizes quality, regulatory rigor, and advanced cancer care, while South Korea combines digital hospital infrastructure with strong medtech innovation. Australia is a mature adopter for telepathology and regional access, particularly where specialist pathology services must cover large geographic distances.

Actionable Recommendations for Industry Leaders

Industry vendors should treat digital pathology as an enterprise transformation program rather than a device purchase. The first priority is a validated roadmap that links scanner deployment, image management, LIS integration, storage architecture, cybersecurity, pathologist training, and clinical governance.

Technology providers should prioritize interoperable platforms, transparent performance data, regulatory readiness, and service models that support multi-site scaling. Healthcare providers should build business cases around turnaround time, subspecialty access, workload balancing, quality assurance, education, and research enablement rather than relying only on direct labor savings.

AI adoption should begin with high-value, narrow use cases such as quality control, triage, or biomarker quantification support, followed by phased expansion after validation. Companies should also establish data stewardship policies, algorithm monitoring, procurement standards, and cross-functional governance involving pathology, IT, compliance, oncology, and executive stakeholders.

Research Methodology

This executive summary reflects a structured secondary and primary research approach aligned with established market intelligence standards. Insights are derived from verified public sources, including regulatory databases, device authorizations, European regulatory frameworks, CAP guidance, peer-reviewed pathology literature, national digital health programs, product documentation, hospital digitization evidence, and clinical implementation studies.

The analysis triangulates demand indicators across clinical adoption, regulatory maturity, installed infrastructure, oncology testing needs, workforce constraints, technology readiness, and procurement behavior. Regional, group, and country insights are assessed through comparable variables such as healthcare expenditure, cancer diagnostics capacity, digital health policy, telemedicine infrastructure, and laboratory consolidation.

Claims are limited to evidence-backed observations and clearly established market patterns. The methodology avoids unsupported market sizing assumptions and emphasizes validated developments in whole slide imaging, AI-enabled pathology, interoperability, and clinical implementation.

Conclusion

Digital pathology is entering a scale-up phase as healthcare systems move from isolated pilots to enterprise imaging strategies. Whole slide imaging, AI-enabled workflow support, cloud-ready image management, and interoperable data infrastructure are becoming core elements of modern pathology operations.

The strongest market opportunities will emerge where technology improves diagnostic access, quality, speed, and consistency without disrupting pathologist accountability. Organizations that invest in validation, interoperability, governance, and change management will be better positioned to capture the clinical and operational value of digital pathology.

As AI and computational pathology mature, the field will increasingly connect tissue images with molecular, clinical, and treatment data. This convergence positions digital pathology as a foundational capability for precision medicine, oncology innovation, and the future of data-driven diagnostics.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Digital Pathology Market, by Type
7.1. Human Pathology
7.2. Veterinary Pathology
8. Digital Pathology Market, by Product
8.1. Hardware
8.1.1. Displays
8.1.1.1. Consumer off the Shelf
8.1.1.2. Medical Grade
8.1.1.3. Professional Grade
8.1.2. Scanners
8.1.2.1. Brightfield Scanners
8.1.2.2. Fluorescence Scanners
8.1.3. Storage Systems
8.2. Services
8.2.1. Consulting & Implementation Services
8.2.2. Maintenance & Support Services
8.2.3. Training Services
8.3. Software
8.3.1. Image Management Systems (IMS)
8.3.2. Laboratory Information Systems (LIS)
8.3.3. Picture Archiving and Communication Systems (PACS)
9. Digital Pathology Market, by Laboratory Throughput
9.1. Low-Throughput
9.2. Medium-Throughput
9.3. High-Throughput
10. Digital Pathology Market, by Deployment Model
10.1. On-Premises
10.2. Cloud-Based
10.3. Hybrid
11. Digital Pathology Market, by Application
11.1. Biomarker Discovery
11.2. Disease Diagnosis
11.2.1. Infectious Diseases
11.2.2. Neurology
11.2.3. Oncology
11.3. Drug Discovery & Development
11.4. Telepathology
11.5. Toxicology Studies
11.6. Training & Education
12. Digital Pathology Market, by End User
12.1. Academic & Research Institutes
12.2. Contract Research Organizations
12.3. Government & Regulatory Bodies
12.4. Hospitals & Diagnostic Labs
12.5. Pharmaceutical & Biotechnology Companies
13. Asia-Pacific Digital Pathology Market
14. Europe Digital Pathology Market
15. North America Digital Pathology Market
16. Africa Digital Pathology Market
17. Latin America Digital Pathology Market
18. Middle East Digital Pathology Market
19. NATO Digital Pathology Market
20. G7 Digital Pathology Market
21. European Union Digital Pathology Market
22. BRICS Digital Pathology Market
23. ASEAN Digital Pathology Market
24. GCC Digital Pathology Market
25. United States Digital Pathology Market
26. China Digital Pathology Market
27. Germany Digital Pathology Market
28. Japan Digital Pathology Market
29. India Digital Pathology Market
30. United Kingdom Digital Pathology Market
31. France Digital Pathology Market
32. Canada Digital Pathology Market
33. Australia Digital Pathology Market
34. Italy Digital Pathology Market
35. South Korea Digital Pathology Market
36. Russia Digital Pathology Market
37. Brazil Digital Pathology Market
38. Mexico Digital Pathology Market
39. Spain Digital Pathology Market
40. Competitive Landscape
40.1. Market Concentration Analysis, 2025
40.1.1. Concentration Ratio (CR)
40.1.2. Herfindahl Hirschman Index (HHI)
40.2. Recent Developments & Impact Analysis, 2025
40.3. Product Portfolio Analysis, 2025
40.4. Benchmarking Analysis, 2025
41. Company Profiles
41.1. 3DHISTECH Ltd.
41.2. Aiforia Technologies PLC
41.3. Aignostics GmbH
41.4. Akoya Biosciences
41.5. Charles River Laboratories
41.6. Corista LLC
41.7. Danaher Corporation
41.8. Deep Bio Inc.
41.9. Epredia
41.10. F. Hoffmann-La Roche Ltd.
41.11. FUJIFILM Holdings Corporation
41.12. General Electric Company
41.13. Gestalt Diagnostics Ltd.
41.14. Hamamatsu Photonics K.K.
41.15. Huron Digital Pathology
41.16. Ibex Medical Analytics Ltd.
41.17. Indica Labs
41.18. Koninklijke Philips N.V.
41.19. Laboratory Corporation of America Holdings
41.20. Mikroscan Technologies, Inc.
41.21. Mindpeak GmbH
41.22. Motic
41.23. Nikon Corporation
41.24. Olympus Corporation
41.25. OptraSCAN Inc.
41.26. Owkin, Inc.
41.27. Pathcore Inc.
41.28. PathPresenter Corporation
41.29. PerkinElmer, Inc.
41.30. Proscia, Inc.
41.31. Qritive Inc.
41.32. Quest Diagnostics Incorporated
41.33. Sectra AB
41.34. Visiopharm A/S
41.35. Xybion Digital Inc.
List of Figures
FIGURE 1. GLOBAL DIGITAL PATHOLOGY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL DIGITAL PATHOLOGY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL DIGITAL PATHOLOGY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL DIGITAL PATHOLOGY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL DIGITAL PATHOLOGY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL DIGITAL PATHOLOGY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 17. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2025 VS 2032 (%)
FIGURE 19. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2025 VS 2032 (%)
FIGURE 21. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 25. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 37. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. NATO DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. NATO DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. G7 DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. G7 DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. GCC DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 49. GCC DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 50. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. CHINA DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. GERMANY DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. JAPAN DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. INDIA DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. FRANCE DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. CANADA DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. AUSTRALIA DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. ITALY DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. SOUTH KOREA DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. RUSSIA DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. BRAZIL DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 63. MEXICO DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 64. SPAIN DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL DIGITAL PATHOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DIGITAL PATHOLOGY MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL DIGITAL PATHOLOGY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL HUMAN PATHOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL HUMAN PATHOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL HUMAN PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL VETERINARY PATHOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL VETERINARY PATHOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL VETERINARY PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL HARDWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL HARDWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL HARDWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DISPLAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DISPLAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DISPLAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CONSUMER OFF THE SHELF MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CONSUMER OFF THE SHELF MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CONSUMER OFF THE SHELF MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL MEDICAL GRADE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL MEDICAL GRADE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL MEDICAL GRADE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PROFESSIONAL GRADE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PROFESSIONAL GRADE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PROFESSIONAL GRADE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL SCANNERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL SCANNERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BRIGHTFIELD SCANNERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BRIGHTFIELD SCANNERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BRIGHTFIELD SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL FLUORESCENCE SCANNERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL FLUORESCENCE SCANNERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL FLUORESCENCE SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL STORAGE SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL STORAGE SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL STORAGE SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CONSULTING & IMPLEMENTATION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CONSULTING & IMPLEMENTATION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CONSULTING & IMPLEMENTATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL MAINTENANCE & SUPPORT SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL MAINTENANCE & SUPPORT SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL MAINTENANCE & SUPPORT SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL TRAINING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL TRAINING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL TRAINING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL IMAGE MANAGEMENT SYSTEMS (IMS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL IMAGE MANAGEMENT SYSTEMS (IMS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL IMAGE MANAGEMENT SYSTEMS (IMS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL LABORATORY INFORMATION SYSTEMS (LIS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL LABORATORY INFORMATION SYSTEMS (LIS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL LABORATORY INFORMATION SYSTEMS (LIS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL LOW-THROUGHPUT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL LOW-THROUGHPUT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL LOW-THROUGHPUT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL MEDIUM-THROUGHPUT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL MEDIUM-THROUGHPUT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL MEDIUM-THROUGHPUT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL HIGH-THROUGHPUT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL HIGH-THROUGHPUT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL HIGH-THROUGHPUT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ON-PREMISES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ON-PREMISES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ON-PREMISES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL CLOUD-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CLOUD-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL CLOUD-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL HYBRID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL HYBRID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL HYBRID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BIOMARKER DISCOVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BIOMARKER DISCOVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL BIOMARKER DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL DISEASE DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL DISEASE DIAGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL DISEASE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL TELEPATHOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL TELEPATHOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL TELEPATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL TOXICOLOGY STUDIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL TOXICOLOGY STUDIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL TOXICOLOGY STUDIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL TRAINING & EDUCATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL TRAINING & EDUCATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL TRAINING & EDUCATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL GOVERNMENT & REGULATORY BODIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL GOVERNMENT & REGULATORY BODIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL GOVERNMENT & REGULATORY BODIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL HOSPITALS & DIAGNOSTIC LABS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL HOSPITALS & DIAGNOSTIC LABS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL HOSPITALS & DIAGNOSTIC LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 145. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 146. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 147. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 148. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
TABLE 149. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
TABLE 150. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 151. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 152. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
TABLE 153. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 154. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 155. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 156. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 158. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 161. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
TABLE 162. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
TABLE 163. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 164. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 165. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
TABLE 166. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 167. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 168. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 169. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 171. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 172. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 173. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 174. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
TABLE 175. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
TABLE 176. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 177. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 178. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
TABLE 179. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 180. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 181. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 182. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 183. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 184. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 185. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 186. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 187. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
TABLE 188. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
TABLE 189. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 190. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 191. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
TABLE 192. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 193. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 194. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 195. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 196. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 197. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 198. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 199. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 200. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
TABLE 201. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
TABLE 202. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 204. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
TABLE 205. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 206. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 207. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 208. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 209. NATO DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 210. NATO DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 211. NATO DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 212. NATO DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 213. NATO DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
TABLE 214. NATO DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
TABLE 215. NATO DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 216. NATO DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 217. NATO DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
TABLE 218. NATO DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 219. NATO DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 220. NATO DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 221. NATO DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 222. G7 DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 223. G7 DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 224. G7 DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 225. G7 DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 226. G7 DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
TABLE 227. G7 DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
TABLE 228. G7 DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 229. G7 DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 230. G7 DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
TABLE 231. G7 DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 232. G7 DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 233. G7 DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 234. G7 DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 249. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 250. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 251. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 252. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
TABLE 253. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
TABLE 254. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 255. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 256. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
TABLE 257. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 258. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 259. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 260. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 261. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 262. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 263. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 264. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 265. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
TABLE 266. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
TABLE 267. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 268. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 269. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
TABLE 270. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 271. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 272. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 273. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 274. GCC DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 275. GCC DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 276. GCC DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 277. GCC DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 278. GCC DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
TABLE 279. GCC DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
TABLE 280. GCC DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 281. GCC DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 282. GCC DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
TABLE 283. GCC DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 284. GCC DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 285. GCC DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 286. GCC DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 287. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 288. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 289. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 290. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 291. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
TABLE 292. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
TABLE 293. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 294. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 295. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
TABLE 296. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 297. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 298. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 299. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 300. CHINA DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 301. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 302. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 303. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 304. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
TABLE 305. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
TABLE 306. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 307. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 308. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
TABLE 309. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 310. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 311. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 312. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 313. GERMANY DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 314. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 315. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 316. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 317. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
TABLE 318. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
TABLE 319. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 320. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 321. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
TABLE 322. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 323. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 324. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 325. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 326. JAPAN DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 327. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 328. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 329. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 330. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
TABLE 331. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
TABLE 332. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 333. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 334. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
TABLE 335. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 336. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 337. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 338. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 339. INDIA DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 340. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 341. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 342. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 343. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
TABLE 344. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
TABLE 345. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 346. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 347. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
TABLE 348. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 349. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 350. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 351. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 352. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 353. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 354. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 355. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 356. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
TABLE 357. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
TABLE 358. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 359. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE 360. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2018-2032 (USD MILLION)
TABLE 361. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 362. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 363. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 364. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 365. FRANCE DIGITAL PATHOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 366. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 367. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 368. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
TABLE 369. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2018-2032 (USD MILLION)
TABLE 370. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2018-2032 (USD MILLION)
TABLE 371. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 372. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
TABLE

Companies Mentioned

The companies featured in this Digital Pathology market report include:
  • 3DHISTECH Ltd.
  • Aiforia Technologies PLC
  • Aignostics GmbH
  • Akoya Biosciences
  • Charles River Laboratories
  • Corista LLC
  • Danaher Corporation
  • Deep Bio Inc.
  • Epredia
  • F. Hoffmann-La Roche Ltd.
  • FUJIFILM Holdings Corporation
  • General Electric Company
  • Gestalt Diagnostics Ltd.
  • Hamamatsu Photonics K.K.
  • Huron Digital Pathology
  • Ibex Medical Analytics Ltd.
  • Indica Labs
  • Koninklijke Philips N.V.
  • Laboratory Corporation of America Holdings
  • Mikroscan Technologies, Inc.
  • Mindpeak GmbH
  • Motic
  • Nikon Corporation
  • Olympus Corporation
  • OptraSCAN Inc.
  • Owkin, Inc.
  • Pathcore Inc.
  • PathPresenter Corporation
  • PerkinElmer, Inc.
  • Proscia, Inc.
  • Qritive Inc.
  • Quest Diagnostics Incorporated
  • Sectra AB
  • Visiopharm A/S
  • Xybion Digital Inc.

Table Information